Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2014-03-14

FDA Approved: HEMANGEOL — Original Application (Eton Pharmaceuticals, Inc.)

View source ↗

Summary

The FDA approved Hemangeol (propranolol hydrochloride) through an original NDA for the treatment of infantile hemangiomas in pediatric patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • HEMANGEOL (Propranolol hydrochloride)

Snippet

ORIG AP for HEMANGEOL (PROPRANOLOL HYDROCHLORIDE)